Proviva Therapeutics
Shanghai
About Proviva Therapeutics
Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins. It is committed to solving the problem of drug metabolism and the delivery of cytogenic drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $48.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2025)
Industries & Categories
Biotechnology, Life Science, Medical, Therapeutics
Canonical: https://fsome.com/organization/proviva-therapeutics-53834 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.